A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

May 21, 2024

Study Completion Date

May 21, 2024

Conditions

Healthy

Interventions

BIOLOGICAL

Sotatercept

Single subcutaneous injection

OTHER

Placebo

Single subcutaneous injection

Trial Locations (1)

Zhongshan Hospital,Fudan University-Dep. of Clinical Pharmacology (Site 0001), Shanghai

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06843460 - A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021) | Biotech Hunter | Biotech Hunter